Health

6 Philadelphia-Area Companies Land on Deloitte’s 2021 Technology Fast 500 List

November 17, 2021

Six companies in Greater Philadelphia rank among the 500 fastest-growing technology and life sciences companies in North America, according to a new report from Deloitte. Deloitte’s 2021 Technology Fast 500 Rankings, released Wednesday, rank firms based on revenue growth percentage during the period from 2017 to 2020. Qualifying companies had to have operating revenue of […]

Why it Matters That Ben Franklin Tech Partners’ New Team Brings Clinical Experience to Healthcare Investing

November 10, 2021

Ben Franklin Technology Partners of Southeastern Pennsylvania has formed an investment group to support the development of early-stage companies focused on health care technologies and outcomes. The four-person health care investment team will led by Jennifer Hartt, who will serve as its managing director. Since 2006, Hartt has closed more than 150 investments totaling about […]

Why it Matters That Ben Franklin Tech Partners’ New Team Brings Clinical Experience to Healthcare Investing

November 10, 2021

Often times it is the people closest to problems who best understand the solutions. That’s why state-backed seed and early-stage funder Ben Franklin Technology Partners has brought on pros with direct experience in the healthcare field to lead its new Healthcare Investment Group (HIG). HIG Managing Director Jennifer Hartt, Ben Franklin’s former director of investments […]

3 Philadelphia Startups Land Six-Figure Investments in PACT’s ‘Lion’s Den’

November 8, 2021

Three Philadelphia-area startups secured hundreds of thousands of dollars in growth capital from The Lion’s Den, a “Shark Tank”-like production hosted by local investors. Dozens of local startup founders, from early-stage companies to fast-growing technology and life sciences firms, pitched their ventures during the Philadelphia Alliance for Capital and Technologies’ 2021 Capital Conference on Thursday […]

Navrogen Enters Into CRADA With USAMRIID To Test Proprietary Small Molecule NK Cell Activators Against SARS-COV-2 Infection

September 16, 2021

Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The CRADA is focused on testing Navrogen’s small molecule NK cell activating agents on suppressing propagation of SARS-COV-2. Researchers […]

Navrogen Raises $3M in Venture Capital Financing to Advance Cancer Therapy Platform

September 3, 2021

A 4-year-old biotechnology company based on the campus of Cheyney University of Pennsylvania has raised $3 million in a venture capital financing. Navrogen Inc. plans to use the proceeds from the seed funding round to support its technology platform being used to develop potential new therapies targeting immunosuppressed cancers and immune-mediated diseases. The financing was […]

Centers for Medicare & Medicaid Services Issues New Code for Encala®

September 1, 2021

Envara Health, a company committed to making significant advancements in the field of clinical nutrition, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a new Healthcare Common Procedure Coding System (HCPCS) code for Encala®, a structured lipid matrix powder for oral administration. This decision establishes the S9432 code, “Medical Food […]

Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV

August 30, 2021

Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced that the Temple University team collaborating with Excision on a project, CRISPR for Cure, has received a Martin Delaney Grant from the National Institutes of Health (NIH) of $4.8 million on an annual basis for the next five years […]

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare

August 27, 2021

Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic company and emerging leader in precision medicine focused on host response diagnostics. Predigen’s acquisition will expand Biomeme’s capabilities across infectious disease and clinical microbiology, business management, and commercialization. redigen’s portfolio includes flagship host gene […]

Navrogen Announces The Closing Of $3.2M Funding To Support Its Humoral Immuno-Oncology Platform Discovery Technologies And Preclinical Pipeline

August 10, 2021

Navrogen, Inc. announced today that it has raised $3.2M in convertible note financing to support its operations, Humoral Immuno-Oncology (HIO) discovery platform and preclinical therapeutic pipeline activities. The financing was led by Ben Franklin Technology Partners of South Eastern Pennsylvania and a number of private investors. Previous clinical studies have confirmed that tumors produce immune […]